Diagnostic imaging in neuroendocrine tumors

J Nucl Med. 2014 Oct;55(10):1576-7. doi: 10.2967/jnumed.114.147082. Epub 2014 Sep 18.

Authors

Luigi Mansi¹, Vincenzo Cuccurullo²

Affiliations

¹ Seconda Università di Napoli Naples, Italy luigi.mansi@unina2.it.
² Seconda Università di Napoli Naples, Italy.

PMID: 25236352
DOI: 10.2967/jnumed.114.147082

No abstract available

MeSH terms

Cost-Benefit Analysis
Diagnostic Imaging / economics
Heterocyclic Compounds, 1-Ring / chemistry
Humans
Neuroendocrine Tumors / diagnosis*
Neuroendocrine Tumors / diagnostic imaging*
Peptides / chemistry
Positron-Emission Tomography / methods
Probability
Reproducibility of Results
Risk
Somatostatin / analogs & derivatives
Somatostatin / chemistry
Somatostatin / economics
Tomography, X-Ray Computed / methods

Substances

Heterocyclic Compounds, 1-Ring
Peptides
1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid
Somatostatin
pentetreotide